FDA Inspection 1178488 — Vitalant
The FDA completed an inspection of Vitalant on August 9, 2022 in Neptune, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 9, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Neptune, NJ (United States)